BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Vitiello A, La Porta R, D'Aiuto V, Ferrara F. Pharmacological approach for the reduction of inflammatory and prothrombotic hyperactive state in COVID-19 positive patients by acting on complement cascade. Hum Immunol 2021;82:264-9. [PMID: 33632561 DOI: 10.1016/j.humimm.2021.01.007] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 9.0] [Reference Citation Analysis]
Number Citing Articles
1 Utebay D, Seeger H, Müller AMS, David S. Complement inhibition for the treatment of COVID-19 triggered thrombotic microangiopathy with cardiac failure: a case report. Eur Heart J Case Rep 2021;5:ytab386. [PMID: 34661055 DOI: 10.1093/ehjcr/ytab386] [Reference Citation Analysis]
2 Vitiello A, Ferrara F. Physiopathology and prospectives for therapeutic treatment of pulmonary fibrotic state in COVID-19 patients. Curr Res Pharmacol Drug Discov 2021;2:100056. [PMID: 34870154 DOI: 10.1016/j.crphar.2021.100056] [Reference Citation Analysis]
3 Ferrara F, Vitiello A. The advantages of drug treatment with statins in patients with SARS-CoV-2 infection. Wien Klin Wochenschr 2021. [PMID: 33779831 DOI: 10.1007/s00508-021-01845-8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Vitiello A, Ferrara F. Pharmacological agents modifying the renin angiotensin and natriuretic peptide systems in COVID-19 patients. Wien Klin Wochenschr 2021. [PMID: 33877436 DOI: 10.1007/s00508-021-01855-6] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
5 Antala S, Diamond T, Kociolek LK, Shah AA, Chapin CA. Severe Hepatitis in Pediatric Coronavirus Disease 2019. J Pediatr Gastroenterol Nutr 2022;74:631-5. [PMID: 35149651 DOI: 10.1097/MPG.0000000000003404] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
6 Vitiello A, Ferrara F. Plausible Positive Effects of Statins in COVID-19 Patient. Cardiovasc Toxicol 2021;21:781-9. [PMID: 34255300 DOI: 10.1007/s12012-021-09674-x] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
7 Vitiello A, Ferrara F. Perspectives of association Baricitinib/Remdesivir for adults with Covid-19 infection. Mol Biol Rep 2021. [PMID: 34839450 DOI: 10.1007/s11033-021-06888-8] [Reference Citation Analysis]
8 Vitiello A, Ferrara F, Zovi A, Trama U, Boccellino M. Pregnancy and COVID-19, focus on vaccine and pharmacological treatment. Journal of Reproductive Immunology 2022. [DOI: 10.1016/j.jri.2022.103630] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Vitiello A, Ferrara F. Pharmacotherapy Based on ACE2 Targeting and COVID-19 Infection. Int J Mol Sci 2022;23:6644. [PMID: 35743089 DOI: 10.3390/ijms23126644] [Reference Citation Analysis]
10 Vitiello A, Ferrara F. Colchicine and SARS-CoV-2: Management of the hyperinflammatory state. Respir Med 2021;178:106322. [PMID: 33550151 DOI: 10.1016/j.rmed.2021.106322] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 11.0] [Reference Citation Analysis]
11 Vitiello A, Ferrara F. Low Molecular Weight Heparin, Anti-inflammatory/Immunoregulatory and Antiviral Effects, a Short Update. Cardiovasc Drugs Ther 2021. [PMID: 34460031 DOI: 10.1007/s10557-021-07251-6] [Reference Citation Analysis]
12 Savla SR, Prabhavalkar KS, Bhatt LK. Cytokine storm associated coagulation complications in COVID-19 patients: Pathogenesis and Management. Expert Rev Anti Infect Ther 2021;:1-17. [PMID: 33832398 DOI: 10.1080/14787210.2021.1915129] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 5.0] [Reference Citation Analysis]
13 Vitiello A, Ferrara F, Troiano V, La Porta R. COVID-19 vaccines and decreased transmission of SARS-CoV-2. Inflammopharmacology 2021. [PMID: 34279767 DOI: 10.1007/s10787-021-00847-2] [Reference Citation Analysis]
14 Jiménez D, Torres Arias M. Immunouniverse of SARS-CoV-2. Immunol Med 2022;:1-39. [PMID: 35502127 DOI: 10.1080/25785826.2022.2066251] [Reference Citation Analysis]
15 Ferrara F, Vitiello A. Scientific Hypothesis for Treatment of COVID-19's Lung Lesions by Adjusting ACE/ACE2 Imbalance. Cardiovasc Toxicol 2021;21:498-503. [PMID: 33835386 DOI: 10.1007/s12012-021-09649-y] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 5.0] [Reference Citation Analysis]
16 Napolitano F, Di Spigna G, Vargas M, Iacovazzo C, Pinchera B, Spalletti Cernia D, Ricciardone M, Covelli B, Servillo G, Gentile I, Postiglione L, Montuori N. Soluble Urokinase Receptor as a Promising Marker for Early Prediction of Outcome in COVID-19 Hospitalized Patients. J Clin Med 2021;10:4914. [PMID: 34768433 DOI: 10.3390/jcm10214914] [Reference Citation Analysis]
17 Vitiello A, La Porta R, Ferrara F. The Role of Vitamin C in the Treatment of Sepsis. Drugs Ther Perspect. [DOI: 10.1007/s40267-022-00895-w] [Reference Citation Analysis]
18 Vitiello A, Ferrara F. Risk of drug-induced cardiac arrhythmia during COVID-19 therapeutic treatment. Egypt Heart J 2021;73:103. [PMID: 34792677 DOI: 10.1186/s43044-021-00228-8] [Reference Citation Analysis]
19 Ferrara F, Santilli P, Vitiello A, Forte G, D'Aiuto V. Logistics management provides greater efficiency, governance and compliance. Int J Clin Pharm 2021. [PMID: 34121155 DOI: 10.1007/s11096-021-01283-6] [Reference Citation Analysis]
20 Vitiello A, Ferrara F. A short focus, azithromycin in the treatment of respiratory viral infection COVID-19: efficacy or inefficacy? Immunol Res 2021. [PMID: 34739696 DOI: 10.1007/s12026-021-09244-x] [Reference Citation Analysis]